KD with GS (n = 10) | KD without GS (n = 1254) | p value | |
---|---|---|---|
Male, n (%) | 2(20.0) | 731(58.3) | 0.021 |
Age, years | 5.9(4.3–6.7) | 2.2(1.2–3.6) | <0.001 |
Clinical manifestations | |||
Rash | 5(50.0) | 939(74.9) | 0.134 |
Edema & erythema of the extremities | 3(30.0) | 715(57.0) | 0.111 |
Bilateral bulbar conjunctive injection | 8(80.0) | 1138(90.7) | 0.226 |
Erythema of oral and pharyngeal mucosa | 8(80.0) | 1142 (91.1) | 0.256 |
Cervical lymphadenopathy | 10(100.0) | 647(51.6) | 0.002 |
Fever duration before IVIG administration, days | 6.0(4.8–7.3) | 6.0(5.0–7.0) | 0.916 |
Incomplete KD | 6(60.0) | 460(36.7) | 0.186 |
IVIG resistance | 0(0.00) | 188(15.0) | 0.374 |
Coronary artery lesions | 0(0.00) | 125(10.6) | 0.292 |
Laboratory examinations | |||
White blood cell, ×109/L | 14.6(12.5–18.8) | 14.0(11.0–17.4) | 0.744 |
Neutrophil count, % | 79.9(77.2–91.7) | 68.3(58.0–78.6) | 0.001 |
Hemoglobin, g/L | 108.0(99.3–117.5) | 109.0(102.0–116.0) | 0.737 |
Platelet count, ×109/L | 313(268–350) | 325(267–395) | 0.344 |
C-reactive protein, mg/L | 111.0(69.5–155.5) | 76.0(45.0–114.0) | 0.155 |
Erythrocyte sedimentation rate, mm/h | 102.0(59.0–124.0) | 66.0(46.0–87.0) | 0.018 |
Aspartate aminotransferase, U/L | 34.5(27.0–56.5) | 34.0(26.0–52.0) | 0.573 |
Alanine aminotransferase, U/L | 25.5(13.0–39.0) | 37.0(21.0–79.0) | 0.332 |
Albumin, g/L | 36.0(31.7–42.3) | 37.5(34.1–40.9) | 0.667 |
Total bilirubin, umol/L | 9.2(7.1–15.5) | 6.3(4.0–10.0) | 0.858 |
Creatinine, umol/L | 30.0(25.0–41.5) | 28.0(23.0–33.0) | 0.839 |
Urea nitrogen, umol/L | 2.7(2.3–4.9) | 2.9(2.2–4.0) | 0.429 |
Serum sodium, mmol/L | 138.2(135.1–138.2) | 136.9(134.0–139.0) | 0.880 |
Potassium, mmol/L | 4.0(3.7–4.1) | 4.1(3.7–4.5) | 0.396 |